Related Experiment Video
Updated: Nov 12, 2025
Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
COVID-19 Management in Pediatrics
Insights
This article details the management of Coronavirus disease 2019 (COVID-19) in children and adolescents. It covers current understanding, risks, and implications for healthcare providers, focusing on pediatric care during the evolving pandemic.
Area of Science:
- Pediatric Infectious Diseases
- Public Health
- Epidemiology
Background:
- Coronavirus disease 2019 (COVID-19) is a significant global pandemic.
- While vaccines are emerging, disease-specific therapies remain limited.
- Children are generally less affected but remain susceptible, especially neonates and those with comorbidities.
Purpose of the Study:
- To provide comprehensive COVID-19 management strategies for pediatric populations.
- To outline implications for nursing and advanced practice providers in pediatric care.
- To address the evolving landscape of the pandemic, including virus mutations and vaccination.
Main Methods:
- Review of current scientific literature on COVID-19 in children.
- Analysis of epidemiological data and clinical presentations.
- Synthesis of guidelines for pediatric COVID-19 management.
Main Results:
- COVID-19 severity varies in children, with higher risks for neonates and those with underlying health conditions.
- Multisystem inflammatory syndrome in children (MIS-C) is a severe complication.
- The pandemic's dynamics are shifting with new variants and increasing vaccination efforts.
Conclusions:
- Effective management of COVID-19 in children requires tailored approaches considering age and comorbidities.
- Healthcare providers need updated knowledge on pediatric COVID-19, including MIS-C.
- Continuous adaptation to the pandemic's evolution is crucial for pediatric care.
Abstract:
Coronavirus disease 2019 (COVID-19) is a deadly global pandemic, with scientific efforts improving our understanding of this novel coronavirus. No proven disease-specific therapies exist, although 2 vaccines have been recently approved by the United States Food and Drug Administration under emergency use authorization, and several others are in development or phase III clinical trial testing. COVID-19 presents in greater severity in the medically fragile, obese, elderly, and socially disadvantaged, and children in general are less affected. All children are at risk, but those with comorbidities and neonates are more susceptible. The multisystem inflammatory syndrome is a severe version which can present in any child with a recent COVID-19 infection. The face of the pandemic has been changing in the last few months, with recent increasing cases, virus mutations, and onset of vaccination. This article provides COVID-19 management for children and adolescents and implications for nursing and advanced practice providers.
More Related Videos
Related Concept Videos
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:29Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
01:26Tonsillitis II: Management
01:24Cystic Fibrosis: Management
Sinus disease and chronic...